Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Jamerson

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of the American Society of Nephrology : JASN|November 1, 2018
Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) StudyNisha Bansal, Dawei Xie, Daohang Sha, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 27, 2016
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL TrialKatherine R Tuttle, Lance D Dworkin, William Henrich, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2025
Improvements in Blood Pressure Control and the Hypertension Care Continuum Over 2 Years in Urban Haiti Amidst Civil UnrestMiranda Metz, Rodney Sufra, Anju Ogyu, et al.
International Journal of Nephrology and Renovascular Disease|April 10, 2019
Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) studyTian Chen, Pamela Brewster, Katherine R Tuttle, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
The rationale and design of the AASK cohort studyLawrence J Appel, John Middleton, Edgar R Miller, et al.
American Journal of Hypertension|May 21, 2025
Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive PatientsEirik Olsen, Camilla L Søraas, Roland E Schmieder, et al.
European Journal of Internal Medicine|December 18, 2024
Effects of valsartan vs amlodipine and achieved lower blood pressure on the incidence of end-stage kidney disease: The VALUE TrialEirik Olsen, Kenneth Jamerson, Roland E Schmieder, et al.
JAMA|November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright, George Bakris, Tom Greene, et al.
Plos One|March 18, 2017
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosisChristopher A Drummond, Pamela S Brewster, Wencan He, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of the American Society of Nephrology : JASN|November 1, 2018
Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) StudyNisha Bansal, Dawei Xie, Daohang Sha, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 27, 2016
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL TrialKatherine R Tuttle, Lance D Dworkin, William Henrich, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2025
Improvements in Blood Pressure Control and the Hypertension Care Continuum Over 2 Years in Urban Haiti Amidst Civil UnrestMiranda Metz, Rodney Sufra, Anju Ogyu, et al.
International Journal of Nephrology and Renovascular Disease|April 10, 2019
Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) studyTian Chen, Pamela Brewster, Katherine R Tuttle, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
The rationale and design of the AASK cohort studyLawrence J Appel, John Middleton, Edgar R Miller, et al.
American Journal of Hypertension|May 21, 2025
Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive PatientsEirik Olsen, Camilla L Søraas, Roland E Schmieder, et al.
European Journal of Internal Medicine|December 18, 2024
Effects of valsartan vs amlodipine and achieved lower blood pressure on the incidence of end-stage kidney disease: The VALUE TrialEirik Olsen, Kenneth Jamerson, Roland E Schmieder, et al.
JAMA|November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright, George Bakris, Tom Greene, et al.
Plos One|March 18, 2017
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosisChristopher A Drummond, Pamela S Brewster, Wencan He, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
Pageof 5